AbbVie acquisitions in 2026: 1 reported deal
This page lists 1 reported deal involving AbbVie. The latest, on Aug 29, 2026: ad-hoc-news.de reported "Karuna Therapeutics stock steady with AbbVie deal and schizophrenia drug progress."
Public (ABBV)Pharmaceutical Manufacturing10,000+ employeesabbvie.comLinkedIn
- Reported
- 1
- Last 90 days
- 1
- Latest
- Aug 29, 2026
Acquisitions · latest 1
Latest reported AbbVie deals
| Event | What the source reported | Value | Date |
|---|---|---|---|
| Acquisition | Karuna Therapeutics stock steady with AbbVie deal and schizophrenia drug progressAbbVie has a planned acquisition of Karuna Therapeutics Inc., a deal that was announced in late 2023. | Not stated |
- Karuna Therapeutics stock steady with AbbVie deal and schizophrenia drug progressWith Karuna Therapeutics Inc.
Signal API · MCP
Track AbbVie with the Signal API
One POST /v1/companies/enrich call with abbvie.com returns AbbVie acquisitions signals (news, sec-8k), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "abbvie.com",
"signal_types": ["news","sec-8k"],
"signal_subtypes": ["acquires","merges_with","acquisitionAnnounced",
"acquisitionCompleted"],
"limit": 20
}'Same industry
Acquisitions at related companies
Questions about AbbVie acquisitions
What deals has AbbVie been linked to?
Source. News reports and SEC 8-K filings about acquisitions and mergers.
Method. Stories about the same deal within 14 days merge into one row. Deal values show only when the source states them in USD.
Data as of .